Artemy V. Orlov

Artemy V. Orlov

Auto-generated profile, based on publicly available information

Artemy V. Orlov

State Scientific Center of the Russian Federation Institute of Biomedical Problems of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Vascular Health and Risk Management
Verified
Journal Article
Open access
IPIgor N Posokhov
Igor N Posokhov
TKTatyana Y Kuznetsova
Tatyana Y Kuznetsova
VKViktoria Korneva
Viktoria Korneva
EBEvgeniya N Bryantseva
Evgeniya N Bryantseva
VBVitaliy S Barkan
Vitaliy S Barkan
ARAnatoly N Rogoza
Anatoly N Rogoza
The purpose of this study was to examine the pulse wave velocity, aortic augmentation index corrected for heart rate 75 (AIx@75), and central systolic and diastolic blood pressure during 24-hour monitoring in normotensive volunteers. Overall, 467 subjects (206 men and 261 women) were recruited in this study. Participants were excluded from the study if they were less than 19 years of age, had blood test abnormalities, had a body mass index greater than 27.5 kg/m2, had impaired glucose tolerance, or had hypotension or hypertension. Ambulatory blood pressure monitoring (ABPM) with the BPLab® device was performed in each subject. ABPM waveforms were analyzed using the special automatic Vasotens® algorithm, which allows the calculation of pulse wave velocity, AIx@75, central systolic and diastolic blood pressure for “24-hour”, “awake”, and “asleep” periods. Circadian rhythms and sex differences in these indexes were identified. Pending further validation in prospective outcome-based studies, our data may be used as preliminary diagnostic values for the BPLab ABPM additional index in adult subjects.

1 February 2014 in Medical Devices: Evidence and Research
Verified
Journal Article
Open access
IPIgor N Posokhov
Igor N Posokhov
AKAleksandra Konradi
Aleksandra Konradi
ESEugeny V Shlyakhto
Eugeny V Shlyakhto
OMOleg V Mamontov
Oleg V Mamontov
AOArtemy V Orlov
Artemy V Orlov
ARAnatoly N Rogoza
Anatoly N Rogoza
Day-to-day repeatability of the Pulse Time Index of Norm Igor N Posokhov,1 Aleksandra O Konradi,2 Eugeny V Shlyakhto,2 Oleg V Mamontov,2 Artemy V Orlov,3 Anatoly N Rogoza4 1Hemodynamic Laboratory Ltd, Nizhniy Novgorod, 2Almazov Federal Heart, Blood and Endocrinology Centre, Saint Petersburg, 3Department 65 Competitive System Analysis, National Research Nuclear University, Moscow, 4Cardiology Research Center, Moscow, Russia The pulse wave velocity (PWV) threshold for hypertensive target organ damage is presently set at 10 meters per second. New 24-hour monitors (eg, BPLab® and Vasotens®) provide several PWV measurements over a period of 24–72 hours. A new parameter, ie, the Pulse Time Index of Norm (PTIN), can be calculated from these data. The PTIN is defined as the percentage of a 24-hour period during which the PWV does not exceed 10 meters per second. The aim of the present study was to test the new PTIN for clinical feasibility using day-to-day repeatability analysis. Oscillometrically generated waveform files (n=85), which were previously used for research studies, were reanalyzed using the new 2013 version software of the Vasotens technology program, which enables calculation of PTIN. The intraclass correlation coefficient was 0.98 and Cronbach's alpha was 0.97, indicating that the PTIN has excellent day-to-day repeatability and internal consistency. The present results show adequate repeatability, and PTIN assessment using the Vasotens technology appears to be feasible. Keywords: pulse wave velocity, ambulatory, 24-hour, monitoring, Pulse Time Index of Norm, arterial stiffness

28 March 2017 in Cholesterol
Verified
Journal Article
Open access
PDF file
VKV. A. Korneva
V. A. Korneva
TKTatiana Kuznetsova
Tatiana Kuznetsova
TBT. Yu. Bogoslovskaya
T. Yu. Bogoslovskaya
DPDmitry Polyakov
Dmitry Polyakov
VVV. B. Vasilyev
V. B. Vasilyev
MMM. Yu. Mandelshtam
M. Yu. Mandelshtam
Familial hypercholesterolaemia (FH) is a rare disease that tends to be diagnosed lately. In Russia, the genetic and phenotypic characteristics of the disease are not well defined. We investigated 102 patients with definite FH. In 52 of these patients (50.9%) genetic analysis was performed, revealing pathogenic mutations of the low density lipoprotein (LDL) receptor gene in 22 patients. We report here five mutations of the LDL receptor gene found in the Karelian FH sample for the first time. The detection rate of mutations in definite FH patients was 42.3%. Two groups of patients with a definite diagnosis of FH according to the Dutch Lipid Clinic Network criteria were compared: the first group had putatively functionally important LDL receptor gene mutations, while in the second group LDL receptor gene mutations were excluded by single-strand conformation polymorphism analysis. Total and LDL cholesterol levels were higher in the group with LDL receptor mutations compared to the mutation-free population. The frequency of mutations in patients with LDL cholesterol > 6.5 mmol/L was more than 3 times higher than that in patients with LDL < 6.5 mmol/L. Total and LDL cholesterol levels and the frequency of coronary heart disease and myocardial infarction were higher in the group with definite FH compared to groups with probable and possible FH. Cholesterol figures in FH patients of different age and sex from the Karelian population were comparable.

26 December 2020 in Journal of Clinical Practice
Verified
Journal Article
Open access
OIOlga S. Ivanova
Olga S. Ivanova
EMElena Y. Maychuk
Elena Y. Maychuk
IVIrina V. Voevodina
Irina V. Voevodina
AOArtemy V. Orlov
Artemy V. Orlov
Background. General and abdominal obesity is widespread among women in the Russian population. The relationship between obesity and arterial stiffness, as a predictor of the development of cardiovascular diseases, in women of different ages remains unclear. Aims: to study the relationship between obesity and arterial stiffness and dynamics of central aortic pressure in women of different ages with preserved and lost reproductive function. Methods. 161 women were examined and divided into 3 groups. Two groups included women with preserved reproductive function: group 1 consisted of 52 young women aged from 18 to 30 years (23.8 5.3 years); group 2 included 54 women aged from 31 years to the menopause (41 5.9 years). Group 3 included 55 postmenopausal women (55.4 5.8 years). All the women underwent a clinical examination with anthropometry; questioning; 24-hour monitoring of the dynamics of blood pressure with measuring the indicators of arterial stiffness and daily aortic central pressure; determination of the carotid-femoral pulse wave velocity (cfPWV); study of vascular stiffness by volume sphygmography. Results. The anthropometric data in groups 2 and 3 were comparable in terms of the prevalence of general obesity (GO). Abdominal obesity (AO) was detected in 19.2% of the 1st group; 51.9% of the 2nd and 76.4% of the 3rd group. In the 1st group AO had the strongest correlation with the aortic pulse wave velocity PWVao (R = 0.41, p = 0.002) and the corrected to HR75 augmentation index Aixao (R = 0.38, p = 0.005). In the 2nd group AO correlates with cfPWV (R = 0.4, p = 0.003); GO with PWVao (R = 0.38, p = 0.005) and aortic cardio-ankle vascular index CAVIao (R = 0.48, p = 0.001). In the 2nd group AO and GO are also interconnected with the central and peripheral pressure. In the 3rd group AO correlates with PWVao (R = 0.33, p = 0.01), cfPWV (R = 0.32, p = 0.02); GO with the index of the double product IDP (R = 0.36, p = 0.01). Conclusions. Obesity, especially its abdominal type, is an important factor determining the development of vascular wall stiffness in women of the reproductive age. It is necessary to conduct a comprehensive assessment of arterial stiffness and daily dynamics of central aortic pressure in women of all ages, suffering from obesity and, first of all, its abdominal type, in order to early diagnose subclinical changes in the vascular wall and central hemodynamic disorders.

13 May 2025 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Open access
PDF file
KDKantemir K. Dzamikhov
Kantemir K. Dzamikhov
AKAleksey I. Kochetkov
Aleksey I. Kochetkov
OOOlga D. Ostroumova
Olga D. Ostroumova
VSVera R. Shastina
Vera R. Shastina
AAAlexander V. Arablinskiy
Alexander V. Arablinskiy
АВАраблинский Александр Владимирович
Араблинский Александр Владимирович
BACKGROUND: Increasing life expectancy is closely related to the increasing burden of polymorbidity, as well as the number of medications per patient of elderly and senile age (polypharmacy). These factors can have a direct and indirect impact on the cognitive and functional status of patients, which is of utmost importance for preserving both, the duration and the quality of life of older patients. AIM: Assessment of functional status of multimorbid elderly patients with essential arterial hypertension depending on the burden and structure of multimorbidity and its possible relationship with cognitive function condition. METHODS: 330 patients aged ≥ 60 years with arterial hypertension (median age 79 years, 50.6% women) were included in the study. All patients underwent assessment of functional status using the Functional Activities Questionnaire (FAQ) and cognitive functions using the Montreal Cognitive Assessment Scale, Mini-Mental State Examination, Alzheimer’s Disease Assessment Scale (Cognitive Subscale). RESULTS: The median total score on the FAQ questionnaire was statistically significantly higher in the atrial fibrillation group [12 (9–14) points] compared to the arterial hypertension group without atrial fibrillation [10 (6–12) points; p = 0.001], in the chronic kidney disease group [11 (8–14) points] than in the group without chronic kidney disease [10 (6–13) points; p = 0.002). The median final FAQ questionnaire score was statistically significantly (p 0.001) higher in the group of patients with a Charlson comorbidity index ≥ 8 points [12 (9–15) points] compared to that in the group of patients with a Charlson index score of 0–4 points [9 (6–11) points]. According to linear regression analysis, there was a statistically significant relationship between the number of FAQ scores, on the one hand, and the patients’ age (R2 = 0.175; β = 0.422), Charlson comorbidity index (R2 = 0.044; β = 0.216), and the results of cognitive functions testing [Mini-Mental State Examination (R2 = 0.348; β = −0.591), Montreal Cognitive Assessment Scale (R2 = 0.286; β = −0.537), Alzheimer’s Disease Assessment Scale (Cognitive Subscale; R2 = 0.345; β = 0.589; p 0.001 in all cases). CONCLUSION: In elderly patients with essential arterial hypertension, the presence of concomitant atrial fibrillation and chronic kidney disease has a negative impact on their functional activity and cognitive status. Decrease in functional activity and deterioration of cognitive functioning of elderly patients with arterial hypertension is also associated with increasing age and burden of multimorbidity (Charlson index).

30 June 2022 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
ASA. G. Sorokina
A. G. Sorokina
AEAnastasia Efimenko
Anastasia Efimenko
OGOlga Grigorieva
Olga Grigorieva
ENEkaterina Novoseletskaya
Ekaterina Novoseletskaya
NBNataliya Basalova
Nataliya Basalova
IOIana Orlova
Iana Orlova
Aim To study the association between vascular wall stiffness and known markers for accumulation of senescent cells in blood, cells, and tissues of old patients. Material and methods This study included male and female patients aged 65 years and older who were referred to an elective surgical intervention, that included a surgical incision in the area of the anterior abdominal wall or large joints and met the inclusion and exclusion criteria. For all patients, traditional cardiovascular (CV) risk factors and arterial wall stiffness (pulse wave velocity, PWV) were evaluated. Also, biomaterials (peripheral blood, skin, subcutaneous adipose tissue) were collected during the surgery and were used for isolation of several cell types and subsequent histological analysis to determine various markers of senescent cells. Results The study included 80 patients aged 65 to 90 years. The correlation analysis identified the most significant indexes that reflected the accumulation of senescent cells at the systemic, tissue, and cellular levels (r>0.3, р<0.05) and showed positive and negative correlations with PWV. The following blood plasma factors were selected as the markers of ageing: insulin-like growth factor 1 (IGF-1), fibroblast growth factor 21 (FGF-21), and vascular endothelium adhesion molecule 1 (VCAM-1). A significant negative correlation between PWV and IGF-1 concentration was found. Among the tissue markers, P16INK, the key marker for tissue accumulation of senescent cells, predictably showed a positive correlation (r=0.394, p<0.05). A medium-strength correlation with parameters of the 96-h increment of mesenchymal stromal cells and fibroblasts and a weak correlation with IL-6 as a SASP (specific senescent-associated secretory phenotype) were noted. Results of the multifactorial linear regression analysis showed that the blood plasma marker, VCAM-1, and the cell marker, 96-h increment of fibroblasts, were associated with PWV regardless of the patient’s age. Conclusion Stiffness of great arteries as measured by PWV significantly correlates with a number of plasma, tissue, and cellular markers for accumulation of senescent cells. This fact suggests PWV as a candidate for inclusion in the panel of parameters for evaluation and monitoring of the biological age during the senolytic therapy.